The Department of Health and Human Services Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Merck Sharp & Dohme LLC, doing business as Merck, to provide 2019 Vaccines for Children. The contract has a potential value of $2,495,643,500.00 and a period of performance from April 1, 2019 to March 31, 2020.
As a major pharmaceutical manufacturer, Merck will deliver a wide range of pediatric and adult vaccines to fulfill the Vaccines for Children program and Section 317(j) immunization grants to the CDC and state health departments. This includes treatments for COVID-19, cancer, hepatitis, influenza, measles, mumps, rubella, meningitis, and other diseases. The contract allows the CDC flexibility in ordering vaccines over the multi-year period to ensure a reliable supply of critical immunizations needed to support the agency's public health initiatives across all 50 states.
Generated 4/29/24, 9:26 AM